Address
250 Campus Drive
Marlborough, MA 01752
United States of America (the)
Phone
508 263 2900
Website
Sector
Healthcare
Industry
Medical - Equipment & Services
Employees
7063
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Stephen MacMillan | Chairman, Chief Executive Officer & President | 3.17M | 1964 |
| Jennifer Schneiders | President of Diagnostic Solutions | 1.11M | 1969 |
| Karleen Oberton | Chief Financial Officer | 1.36M | 1971 |
| Anne Liddy | General Counsel | 1.42M | 1976 |
| Jan Verstreken | Group President of International | 1.44M | 1969 |
| Essex Mitchell | Chief Operating Officer | 1.53M | 1980 |
| Scott Christensen | Senior Vice President of Global Supply Chain & Regulatory Affairs | 0 | N/A |
| Diana De Walt SPHR | Senior Vice President of Global Human Resources | 0 | 1955 |
| Monica Aguirre Berthelot | Vice President & Chief of Staff | 0 | N/A |
| Benjamin Cohn | Vice President & Corporate Controller | 0 | N/A |
| Michael J. Watts | Corporate Vice President of Investor Relations | 0 | N/A |
| Paul Malenchini | Chief Information Officer | 0 | N/A |
| Mark Horvath | President of Breast & Skeletal Health Solutions | 0 | 1963 |
| Mark Irving | Vice President & Corporate Secretary | 0 | N/A |
| Brandon Schnittker | President of GYN Surgical Solutions | 0 | 1985 |
Hologic, Inc., founded in 1985 and headquartered in Marlborough, Massachusetts, is a global medical technology company. It focuses on developing, manufacturing, and marketing diagnostics, medical imaging, and surgical solutions, with a primary emphasis on advancing women's health through early detection and therapeutic interventions. Its operations are structured into four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health, catering to markets across the United States, Europe, Asia-Pacific, and other global territories. In its Diagnostics division, Hologic provides a range of products, including Aptima molecular assays for identifying infectious microorganisms, viral load tests for conditions such as HIV, Hepatitis C, and Hepatitis B, alongside Aptima and Panther Fusion SARS-CoV-2 assays. Other offerings in this segment include the ThinPrep System for cytology applications, the Rapid Fetal Fibronectin Test to evaluate preterm birth risk, and various diagnostic tests for Group B Streptococcus. The Breast Health segment delivers extensive solutions for breast imaging and analytics. These encompass 2D and 3D digital mammography systems, advanced reading workstations, minimally invasive biopsy guidance systems and devices, breast biopsy markers and localization tools, specimen radiology, ultrasound, connectivity solutions, and products for breast-conserving surgery. Within its GYN Surgical offerings, the company supplies the NovaSure Endometrial Ablation System for managing abnormal uterine bleeding, the MyoSure Hysteroscopic Tissue Removal System for excising fibroids, polyps, and other uterine pathologies, and the Fluent Fluid Management System to facilitate liquid distention during hysteroscopic diagnostic and operative procedures. Its Skeletal Health division offers the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, used for minimally invasive orthopedic surgical interventions. The company markets its products through both its direct sales and service personnel, as well as independent distributors and sales representatives.